Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
about
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseQuantitative Imaging Biomarkers of NAFLDHepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjectsNon-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods.Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B.Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patientsNoninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.Non-alcoholic Fatty Liver Disease: A Clinical Update.Grading fatty liver by ultrasound time-domain radiofrequency signal analysis: an in vivo study of rats.Slow-metabolizing ADH1B and inactive heterozygous ALDH2 increase vulnerability to fatty liver in Japanese men with alcohol dependence.A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
P2860
Q26764843-6271362F-E932-475D-BD0D-67FA139CF7CCQ26768664-4316E72A-3815-4AF4-AB2A-0D538DA2BBBEQ28595534-7EED519F-F05E-4A36-88D3-30A8CA6DC005Q30361971-280AD14A-5801-458F-8B8A-3D186217C2EDQ30413672-2826EB84-74A9-42AA-AD91-C790ED37A6A5Q33895173-1CD1206F-8888-4C20-A0A3-A802910E4016Q35173451-32FF1BF3-DC67-484E-A6E4-DFAAEE290230Q37206110-46DE2BAA-7CCE-4FBD-95BF-98392F72B122Q38867829-65800C1C-3024-4BD2-924B-60349D38890BQ40305082-AB8CBF5D-5F00-46E3-9442-B62841521E21Q40354353-5F84A011-C693-4098-9268-63E4E6DCFD8FQ41051779-D231A33A-B5A6-4B34-A5CD-CF01FDD5B89CQ42613401-7FF8F3FA-7E14-4F01-9A6D-B2985D2B6AFEQ47100244-C08887F0-E0AD-4734-B858-FCCCCFC6F26BQ47563558-B082374E-8DF9-4FAC-81B4-154C98D1ECDEQ50074130-BCE354D2-7FE9-4C07-920E-E42FF5644425Q51244039-1D658E0C-A4FA-4354-8581-1FB31D6A9365Q58549444-4FB3D375-1D66-4F0B-82E9-89B16BF64CB5
P2860
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@ast
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@en
type
label
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@ast
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@en
prefLabel
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@ast
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@en
P2093
P2860
P356
P1476
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
@en
P2093
Amol Sharma
Nancy Khov
Thomas R Riley
P2860
P304
P356
10.3748/WJG.V20.I22.6821
P407
P577
2014-06-01T00:00:00Z